» Articles » PMID: 33510936

Icariin Attenuates Endothelial-mesenchymal Transition Via H19/miR-148b-3p/ELF5 in Ox-LDL-stimulated HUVECs

Overview
Publisher Cell Press
Date 2021 Jan 29
PMID 33510936
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is the main cause of cardio-cerebrovascular diseases. Endothelial-mesenchymal transition plays an important role in atherosclerosis. Icariin has a protective effect on atherosclerosis; however, the underlying mechanism remains unclear. In this study, we explored the molecular mechanism underlying the protective function of icariin in oxidized low-density lipoprotein-stimulated human umbilical vein endothelial cells. H19, a long non-coding RNA, was identified to be downregulated in the background of the oxidized low-density lipoprotein-induced endothelial-mesenchymal transition in human umbilical vein endothelial cells. Icariin upregulated H19 expression and inhibited the transformation of endothelial cells into interstitial cells. Overexpression of H19 affected endothelial-mesenchymal transition in oxidized low-density lipoprotein-stimulated human umbilical vein endothelial cells, whereas H19 knockdown reversed endothelial protective effects of icariin and reduced human umbilical vein endothelial cell migration. Knockdown of H19 significantly downregulated oxidized low-density lipoprotein-induced E74-like factor 5 and upregulated miR-148b-3p, which was reversed by icariin. Thus, icariin may play a protective role in atherosclerosis, and H19 may be a potential therapeutic target.

Citing Articles

Circ-USP9X accelerates deep vein thrombosis after fracture by acting as a miR-148b-3p sponge and upregulates SRC kinase signaling inhibitor 1.

Wang Y, Su Q, Tang H, Lin X, Yi Y, Tian Q Clinics (Sao Paulo). 2024; 79:100403.

PMID: 38878321 PMC: 11226750. DOI: 10.1016/j.clinsp.2024.100403.


Elucidating the crosstalk between endothelial-to-mesenchymal transition (EndoMT) and endothelial autophagy in the pathogenesis of atherosclerosis.

Singh B, Cui K, Eisa-Beygi S, Zhu B, Cowan D, Shi J Vascul Pharmacol. 2024; 155:107368.

PMID: 38548093 PMC: 11303600. DOI: 10.1016/j.vph.2024.107368.


Endothelial to mesenchymal transition: at the axis of cardiovascular health and disease.

Hall I, Kishta F, Xu Y, Baker A, Kovacic J Cardiovasc Res. 2024; 120(3):223-236.

PMID: 38385523 PMC: 10939465. DOI: 10.1093/cvr/cvae021.


Xinyang tablet ameliorates sepsis-induced myocardial dysfunction by regulating Beclin-1 to mediate macrophage autophagy and M2 polarization through LncSICRNT1 targeting E3 ubiquitin ligase TRAF6.

Luo Y, Li Y, He L, Tu H, Lin X, Zhao F Chin Med. 2023; 18(1):143.

PMID: 37919806 PMC: 10621131. DOI: 10.1186/s13020-023-00832-7.


Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition.

Yun E, Kwon B, Kim J, Lee A Anim Cells Syst (Seoul). 2023; 27(1):159-170.

PMID: 37554358 PMC: 10405771. DOI: 10.1080/19768354.2023.2244549.


References
1.
Wang Y, Huang Z . Protective effects of icariin on human umbilical vein endothelial cell injury induced by H2O2 in vitro. Pharmacol Res. 2005; 52(2):174-82. DOI: 10.1016/j.phrs.2005.02.023. View

2.
Chen P, Qin L, Baeyens N, Li G, Afolabi T, Budatha M . Endothelial-to-mesenchymal transition drives atherosclerosis progression. J Clin Invest. 2015; 125(12):4514-28. PMC: 4665771. DOI: 10.1172/JCI82719. View

3.
Lapinskas E, Svobodova S, Davis I, Cebon J, Hertzog P, Pritchard M . The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney. Twin Res Hum Genet. 2011; 14(4):316-22. DOI: 10.1375/twin.14.4.316. View

4.
Evrard S, Lecce L, Michelis K, Nomura-Kitabayashi A, Pandey G, Purushothaman K . Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun. 2016; 7:11853. PMC: 4931033. DOI: 10.1038/ncomms11853. View

5.
Xiao-Hong D, Chang-Qin X, Jian-Hua H, Wen-Jiang Z, Bing S . Icariin delays homocysteine-induced endothelial cellular senescence involving activation of the PI3K/AKT-eNOS signaling pathway. Pharm Biol. 2013; 51(4):433-40. DOI: 10.3109/13880209.2012.738332. View